Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
|
|
AVIGEN INC (AVGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/24/2009 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/22/2009 |
4
| CHAHINE KENNETH (Director) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Disposed/sold 25,000 options to buy
@ $29, valued at
$725k
Disposed/sold 75,000 options to buy
@ $38.1875, valued at
$2.9M
Disposed/sold 100,000 options to buy
@ $14.625, valued at
$1.5M
Disposed/sold 37,500 options to buy
@ $8.525, valued at
$319.7k
Disposed/sold 75,000 options to buy
@ $3.53, valued at
$264.8k
Disposed/sold 125,000 options to buy
@ $3.38, valued at
$422.5k
Disposed/sold 33,000 options to buy
@ $3.14, valued at
$103.6k
Disposed/sold 150,000 options to buy
@ $5.062, valued at
$759.3k
Disposed/sold 90,000 options to buy
@ $5.5, valued at
$495k
Disposed/sold 113,324 options to buy
@ $4.42, valued at
$500.9k
|
|
| 12/22/2009 |
4
| SAUTER ANDREW AUGUST (CEO, President and CFO) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Disposed/sold 13,333 options to buy
@ $14.625, valued at
$195k
Disposed/sold 7,500 options to buy
@ $8.525, valued at
$63.9k
Disposed/sold 13,000 options to buy
@ $3.53, valued at
$45.9k
Disposed/sold 20,000 options to buy
@ $3.1272, valued at
$62.5k
Disposed/sold 15,000 options to buy
@ $3.25, valued at
$48.8k
Disposed/sold 11,000 options to buy
@ $3.45, valued at
$38k
Disposed/sold 50,000 options to buy
@ $3.63, valued at
$181.5k
Disposed/sold 50,000 options to buy
@ $5.062, valued at
$253.1k
Disposed/sold 65,000 options to buy
@ $5.5, valued at
$357.5k
Disposed/sold 81,845 options to buy
@ $4.42, valued at
$361.8k
Disposed/sold 4,125 shares
@ $0 |
|
| 12/22/2009 |
4
| Johnson Kirk William (VP Research and Development) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Disposed/sold 70,000 options to buy
@ $6.31, valued at
$441.7k
Disposed/sold 50,000 options to buy
@ $3.38, valued at
$169k
Disposed/sold 16,500 options to buy
@ $3.14, valued at
$51.8k
Disposed/sold 115,000 options to buy
@ $5.062, valued at
$582.1k
Disposed/sold 70,000 options to buy
@ $5.5, valued at
$385k
Disposed/sold 88,141 options to buy
@ $4.42, valued at
$389.6k
|
|
| 12/22/2009 |
4
| PRENDERGAST JOHN K A (Director) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Disposed/sold 10,000 options to buy
@ $3.94, valued at
$39.4k
Disposed/sold 10,000 options to buy
@ $3.99, valued at
$39.9k
Disposed/sold 10,000 options to buy
@ $2.96, valued at
$29.6k
Disposed/sold 20,000 options to buy
@ $5.41, valued at
$108.2k
Disposed/sold 20,000 options to buy
@ $6.73, valued at
$134.6k
Disposed/sold 20,000 options to buy
@ $2.96, valued at
$59.2k
Disposed/sold 39,108 shares
@ $0
Disposed/sold 7,500 options to buy
@ $40.75, valued at
$305.6k
Disposed/sold 5,000 options to buy
@ $14.625, valued at
$73.1k
Disposed/sold 2,500 options to buy
@ $13.02, valued at
$32.6k
Disposed/sold 10,000 options to buy
@ $9.48, valued at
$94.8k
|
|
| 12/22/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2009 |
4
| Southpaw Asset Management LP (10% Owner) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Unknown transaction of 4,884,508 shares
@ $0 |
|
| 12/22/2009 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 12/21/2009 |
4
| Wallace Richard John (Director) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Disposed/sold 30,000 options to buy
@ $5.55, valued at
$166.5k
Disposed/sold 5,000 options to buy
@ $5.41, valued at
$27.1k
Disposed/sold 20,000 options to buy
@ $6.73, valued at
$134.6k
Disposed/sold 20,000 options to buy
@ $2.96, valued at
$59.2k
|
|
| 12/21/2009 |
4
| DILLY STEPHEN GEORGE (Director) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Disposed/sold 30,000 options to buy
@ $6.04, valued at
$181.2k
Disposed/sold 6,667 options to buy
@ $6.73, valued at
$44.9k
Disposed/sold 20,000 options to buy
@ $2.96, valued at
$59.2k
|
|
| 12/21/2009 |
4
| OHRSTROM JAN K (Director) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Disposed/sold 30,000 options to buy
@ $6.04, valued at
$181.2k
Disposed/sold 6,667 options to buy
@ $6.73, valued at
$44.9k
Disposed/sold 20,000 options to buy
@ $2.96, valued at
$59.2k
|
|
| 12/16/2009 |
4
| BURLINGAME ASSET MANAGEMENT, LLC (10% Owner) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Bought 1,280,203 shares
@ $1.3494, valued at
$1.7M
Bought 167,367 shares
@ $1.3186, valued at
$220.7k
Bought 14,159 shares
@ $1.33, valued at
$18.8k
Sold 181,526 shares
@ $1.3001, valued at
$236k
|
|
| 12/16/2009 |
8-K
| Quarterly results |
| 12/15/2009 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 12/09/2009 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 12/07/2009 |
8-K/A
| Financial Statements and Exhibits |
| 11/20/2009 |
4
| HOROVITZ ZOLA P (Director) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Sold 5,000 shares
@ $1.4322, valued at
$7.2k
|
|
| 11/20/2009 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Sold 626 shares
@ $1.5, valued at
$939 |
|
| 11/09/2009 |
10-Q
| Quarterly Report for the period ended September 30, 2009 |
| 10/30/2009 |
4
| BURLINGAME ASSET MANAGEMENT, LLC (10% Owner) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Bought 6,435 shares
@ $1.4766, valued at
$9.5k
Bought 2,000 shares
@ $1.467, valued at
$2.9k
|
|
| 10/23/2009 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 10/23/2009 |
4
| Southpaw Credit Opportunity Master Fund, L.P. (10% Owner) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Bought 459,490 shares
@ $1.53, valued at
$703k
Bought 22,900 shares
@ $1.503, valued at
$34.4k
|
|
| 10/23/2009 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Sold 115,200 shares
@ $1.5, valued at
$172.8k
Sold 80,000 shares
@ $1.5, valued at
$120k
Sold 277,000 shares
@ $1.5, valued at
$415.5k
|
|
| 10/21/2009 |
4
| Southpaw Credit Opportunity Master Fund, L.P. (10% Owner) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Bought 38,039 shares
@ $1.5144, valued at
$57.6k
Bought 20,989 shares
@ $1.5287, valued at
$32.1k
|
|
| 10/14/2009 |
4
| Southpaw Credit Opportunity Master Fund, L.P. (10% Owner) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Bought 882,221 shares
@ $1.53, valued at
$1.3M
Bought 9,150 shares
@ $1.5065, valued at
$13.8k
Bought 8,455 shares
@ $1.508, valued at
$12.8k
Bought 6,433 shares
@ $1.5157, valued at
$9.8k
|
|
| 10/05/2009 |
4
| Southpaw Credit Opportunity Master Fund, L.P. (10% Owner) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Bought 22,131 shares
@ $1.5129, valued at
$33.5k
Bought 19,299 shares
@ $1.52, valued at
$29.3k
Bought 9,057 shares
@ $1.51, valued at
$13.7k
|
|
| 10/05/2009 |
3
| Southpaw Credit Opportunity Master Fund, L.P. (10% Owner) has filed a Form 3 on AVIGEN INC \DE |
| 09/24/2009 |
SC 13G/A
| Bulldog Investors reports a 3.8% stake in Avigen Inc. |
| 09/21/2009 |
4
| BURLINGAME ASSET MANAGEMENT, LLC (10% Owner) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Bought 632 shares
@ $1.45, valued at
$916.4 |
|
| 09/15/2009 |
4
| BURLINGAME ASSET MANAGEMENT, LLC (10% Owner) has filed a Form 4 on AVIGEN INC \DE|
Txns:
| Bought 43,670 shares
@ $1.5122, valued at
$66k
Bought 682,698 shares
@ $1.5397, valued at
$1.1M
|
|
| 09/15/2009 |
3
| BURLINGAME ASSET MANAGEMENT, LLC (10% Owner) has filed a Form 3 on AVIGEN INC \DE |
| 08/26/2009 |
8-K
| Form 8-K - Current report |
| 08/25/2009 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 08/25/2009 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"Agreement and Plan of Merger, by and among MediciNova, Inc., Absolute Merger, Inc. and Avigen, Inc",
"Amendment to Rights Agreement, by and between Avigen, Inc. and American Stock Transfer & Trust Co. LLC",
"Amendment to Management Transition Plan, effective as of August 20, 2009",
"JOINT PRESS RELEASE OF AVIGEN AND MEDICINOVA, DATED AUGUST 21, 2009" |
|
|
|
|